Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorCARLIER, Jerome
dc.contributor.authorROBIN, Florian
dc.contributor.authorPAGES, Nicolas
dc.contributor.authorQUINART, Alice
dc.contributor.authorROY, Maxim
dc.contributor.authorPAUCHARD, Jean-Claude
dc.contributor.authorQUINTANA, Isabelle
hal.structure.identifierLaboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM]
dc.contributor.authorNOUETTE-GAULAIN, Karine
dc.date.accessioned2021-10-26T10:16:10Z
dc.date.available2021-10-26T10:16:10Z
dc.date.issued2021-06
dc.identifier.issn2352-5568en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/112884
dc.description.abstractEnIntroduction: Few studies assess postoperative outcomes after discharge in the ambulatory setting. The aim of this study was to investigate postoperative pain and adverse effects at 24 h and at 7 days after day surgery using an e-health follow-up smartphone-based application named SATELIA®. Materials and methods: This retrospective, observational and monocentric cohort study was conducted at the University Hospital of Bordeaux. All eligible patients for SATELIA® follow-up between May 2018 and June 2019 were screened for the analysis. Data were extracted from two databases. Those with a missing primary outcome were excluded from the analysis. The main outcome was the worst pain score on POD 1, self-reported via SATELIA®. The secondary outcomes were the incidence of adverse effects on POD1, as well as the worst pain score and adverse effects on POD7. Quantitative data were reported by the median (IQR) and categorical data were presented as absolute numbers (%). Results: A total of 2283 patients were screened for analysis, from which 592 were excluded due to missing data for the main outcome; 1691 patients were thus finally included. The median worst pain score at POD 1 was 3.0 (1.0-5.0); 35.5% (n = 601/1691) and 29.1% (n = 492/1691) of the patients reported moderate-to-severe pain at POD1 and POD7, respectively. Conclusion: This retrospective study shows that 35.5% of patients experience moderate-to-severe pain after day surgery. Even if SATELIA® should be further developed and evaluated, it also demonstrates the interest of using phone based software to follow patients after discharge and ensure a better personalised management.
dc.language.isoENen_US
dc.subject.enDay surgery
dc.subject.enmobile application
dc.subject.enPostoperative outcome assessment
dc.subject.enPostoperative pain
dc.title.enPain evaluation after day-surgery using a mobile phone application
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.accpm.2021.100879en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologieen_US
dc.identifier.pubmed33965646en_US
bordeaux.journalAnaesthesia Critical Care & Pain Medicineen_US
bordeaux.volume40en_US
bordeaux.hal.laboratoriesMaladies Rares : Génétique et Métabolisme (MRGM) - UMR 1211en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03403785
hal.version1
hal.date.transferred2021-10-26T10:16:18Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Anaesthesia%20Critical%20Care%20&%20Pain%20Medicine&rft.date=2021-06&rft.volume=40&rft.issue=3&rft.eissn=2352-5568&rft.issn=2352-5568&rft.au=CARLIER,%20Jerome&ROBIN,%20Florian&PAGES,%20Nicolas&QUINART,%20Alice&ROY,%20Maxim&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée